Angioimmunoblastic T-cell lymphoma (patient information): Difference between revisions
No edit summary |
Category |
||
Line 40: | Line 40: | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Hematology]] | |||
[[Category:Immunology]] |
Latest revision as of 03:14, 24 October 2017
Angioimmunoblastic T-cell lymphoma Microchapters |
Differentiating Angioimmunoblastic T-cell lymphoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Angioimmunoblastic T-cell lymphoma (patient information) On the Web |
American Roentgen Ray Society Images of Angioimmunoblastic T-cell lymphoma (patient information) |
FDA on Angioimmunoblastic T-cell lymphoma (patient information) |
CDC on Angioimmunoblastic T-cell lymphoma (patient information) |
Angioimmunoblastic T-cell lymphoma (patient information) in the news |
Blogs on Angioimmunoblastic T-cell lymphoma (patient information) |
Directions to Hospitals Treating Angioimmunoblastic T-cell lymphoma |
Risk calculators and risk factors for Angioimmunoblastic T-cell lymphoma (patient information) |
For the WikiDoc page on this topic, click here
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]